Clinical Trial Update: Study Evaluating Tigecycline Versus Imipenem/Cilastatin in Hospital-Acquired Pneumonia [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing tigecycline to imipenem/cilastatin for hospital-acquired pneumonia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hospital-acquired Pneumonia

Drugs mentioned

• Primaxin (imipenem/cilastatin)
• TYGACIL (tigecycline)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Bacterial Pneumonia | Phase 3 | Status: COMPLETED